Found: 28
Select item for more details and to access through your institution.
Is trastuzumab-induced cardiotoxicity involved in onco-cardiology outcome?
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 7, p. 451, doi. 10.1007/s12094-011-0682-1
- By:
- Publication type:
- Article
Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 2, p. 121, doi. 10.1007/s12094-011-0629-6
- By:
- Publication type:
- Article
Circulating tumour cells in locally advanced breast cancer.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 8, p. 544, doi. 10.1007/s12094-009-0400-4
- By:
- Publication type:
- Article
Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 9, p. 560, doi. 10.1007/s12094-008-0251-x
- By:
- Publication type:
- Article
Successful rectal cancer local recurrence radiofrequency ablation.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 5, p. 300, doi. 10.1007/s12094-008-0202-0
- By:
- Publication type:
- Article
Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 11, p. 826, doi. 10.1007/s12094-006-0139-0
- By:
- Publication type:
- Article
Significance of the immunohistochemical detection of lymph node micrometastases in Stage II Colorectal Carcinoma.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 9, p. 676, doi. 10.1007/s12094-006-0038-4
- By:
- Publication type:
- Article
New target-based agents involve new clinical trial designs.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 8, p. 581, doi. 10.1007/s12094-006-0063-3
- By:
- Publication type:
- Article
Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 1, p. 50, doi. 10.1007/s12094-006-0095-8
- By:
- Publication type:
- Article
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 1, p. 163, doi. 10.1007/s10549-023-07094-9
- By:
- Publication type:
- Article
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4705, doi. 10.3390/cancers14194705
- By:
- Publication type:
- Article
Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1 , CLNS1A, and ILF2 in Luminal Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4118, doi. 10.3390/cancers13164118
- By:
- Publication type:
- Article
Exome array analysis identifies <italic>ETFB</italic> as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 249, doi. 10.1007/s10549-017-4497-9
- By:
- Publication type:
- Article
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 1, p. 169, doi. 10.1007/s10549-010-0860-9
- By:
- Publication type:
- Article
Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer.
- Published in:
- Breast Care, 2020, v. 15, n. 4, p. 428, doi. 10.1159/000503849
- By:
- Publication type:
- Article
Cáncer de mama y COVID-19: cómo podemos adaptarnos a la pandemia y no poner en riesgo a nuestras pacientes.
- Published in:
- Cancer & Chemotherapy Reviews, 2020, v. 15, n. 1, p. 6
- By:
- Publication type:
- Article
New Forms of Administration of Herceptin®.
- Published in:
- Cancer & Chemotherapy Reviews, 2015, v. 10, n. 2, p. 53
- By:
- Publication type:
- Article
Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e53, doi. 10.1002/onco.13531
- By:
- Publication type:
- Article
Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 111, doi. 10.1634/theoncologist.2014-0379
- By:
- Publication type:
- Article
Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 8, p. 917, doi. 10.1634/theoncologist.2012-0479
- By:
- Publication type:
- Article
Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 1, doi. 10.1634/theoncologist.2008-0137
- By:
- Publication type:
- Article
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.886831
- By:
- Publication type:
- Article
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11419, doi. 10.3390/ijms241411419
- By:
- Publication type:
- Article
BRCA1 Alternative splicing landscape in breast tissue samples.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1145-9
- By:
- Publication type:
- Article
BRCA1 Alternative splicing landscape in breast tissue samples.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.605633
- By:
- Publication type:
- Article
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01649-w
- By:
- Publication type:
- Article